PARX HEAL Stock

PRLX

US69916A1051

Delayed OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

22-03-28	Parallax Health Sciences Inc. Announces Executive Changes	CI
22-03-28	Parallax Health Sciences Inc. Terminates Sonia Choi as Interim CEO	CI

Parallax Health Sciences, Inc. focuses on personalized patient care through the use of the Company's Compound Pharmacy (Roxsan, Inc.) and eventually through the diagnostic testing platform capable of diagnosing and monitoring various health issues. The Company's segments include Retail Pharmacy Services (RPS) and Corporate. The RPS segment provides a range of pharmacy services, including retail, compounding and fertility medications. The Corporate segment provides management and administrative services to support the Company. The RPS segment dispenses prescription drugs, both through local channels by direct delivery, as well as mail order. The RPS segment also sells an assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, seasonal merchandise and convenience foods, through the Company's pharmacy. It holds interests in Quality of Life Peace of Mind (QOLPOM). The QOLPOM Hub is a personal medication dispensing and remote monitoring solution.

Employees

Sector

More about the company

Market Cap	2.51M 2.19M 2.07M 1.88M 3.52M 241M 3.53M 24.76M 9.55M 122M 9.43M 9.22M 394M	P/E 2018	1.35x	P/E 2019	-0.94x
Enterprise Value	6.03M 5.26M 4.97M 4.51M 8.45M 579M 8.49M 59.5M 22.96M 294M 22.66M 22.16M 947M	EV / Sales 2018	1,568,116,279x	EV / Sales 2019	136,778,344x
Free-Float	-	Yield 2018 *	-	Yield 2019	-

22-03-28	Parallax Health Sciences Inc. Announces Executive Changes	CI
22-03-28	Parallax Health Sciences Inc. Terminates Sonia Choi as Interim CEO	CI
21-09-29	Parallax Health Sciences, Inc. Appoints Sonia Choi as Interim Chief Executive Officer	CI
21-08-23	Parallax Health Sciences, Inc. Announces Executive Changes	CI
21-07-13	Parallax Health Sciences Inc. Announces Resignation of Paul R. Arena as Chief Executive Officer	CI
21-07-13	Parallax Health Sciences Inc. Announces Management Changes	CI
21-04-08	Parallax Health Sciences, Inc. Announces Resignation of Capt. E. William Withrow Jr. from its Board and Chair of the Compensation Committee, Deputy Chair of the Audit Committee and Co-Chair of the Governance Committee	CI
20-05-18	Parallax Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	CI
20-05-17	Parallax Health Sciences, Inc. Auditor Raises 'Going Concern' Doubt	CI
20-04-09	Parallax Health Sciences, Inc. Announces Executive Changes	CI
20-03-25	Parallax Health Sciences, Inc. Launches Secure Good Health Outcomes Telehealth Application for Immediate Free Download	CI
20-03-24	Parallax Health Sciences, Inc. Updates Progress on Proprietary COVID-19 Rapid Test	CI
20-03-16	Parallax Health Sciences, Inc. Receives Approval on its Registration Into U.S. Government's System for Award Management,	CI

22-05-12	PARALLAX HEALTH SCIENCES, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits (form 8-K)	AQ
22-03-28	PARALLAX HEALTH SCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)	AQ
21-09-29	PARX HEAL : EXECUTIVE AGREEMENT (Form 8-K)	PU
21-09-29	PARALLAX HEALTH SCIENCES, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
21-08-31	PARALLAX HEALTH SCIENCES, INC. : Entry into a Material Definitive Agreement, Other Events (form 8-K)	AQ

Date	Insider	Type	Main position	Quantity	% Market Cap.
1/14/22	Edward Withrow	Others	Director	20,541,826	7.5878%
12/31/21	Edward Withrow	Others	Director	18,921,420	6.9892%
12/31/21	Edward Withrow	Others	Director	1,228,749	-

	2018	2019
Net sales	0.01 0.01 0.01 0.01 0.02 1.13 0.02 0.12 0.04 0.57 0.04 0.04 1.84	0.13 0.11 0.11 0.1 0.18 12.34 0.18 1.27 0.49 6.27 0.48 0.47 20.19
Net income	16.29M 14.2M 13.41M 12.18M 22.82M 1.56B 22.91M 161M 62M 795M 61.19M 59.83M 2.56B	-12.87M -11.22M -10.59M -9.62M -18.02M -1.23B -18.1M -127M -48.97M -628M -48.33M -47.26M -2.02B
Net Debt	2.95M 2.57M 2.43M 2.2M 4.13M 283M 4.14M 29.05M 11.21M 144M 11.07M 10.82M 462M	3.52M 3.07M 2.9M 2.63M 4.93M 338M 4.95M 34.74M 13.41M 172M 13.23M 12.94M 553M

PARX HEAL Stock

Stocks

PRLX

US69916A1051

Valuation: PARX HEAL

Latest news: PARX HEAL

Press Releases: PARX HEAL

Latest insider transactions

Financials

Company Profile